Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy

• Published in: Theranostics 2018-01, Vol.8 (9), p.2329-2347
• Main Authors: Tan, Zheqiong, Xiao, Lanbo, Tang, Min, Bai, Fang, Li, Jiangjiang, Li, Liling, Shi, Feng, Li, Namei, Li, Yueshuo, Du, Qianqian, Lu, Jingchen, Weng, Xinxian, Yi, Wei, Zhang, Hanwen, Fan, Jia, Zhou, Jian, Gao, Qiang, Onuchic, José N, Bode, Ann M, Luo, Xiangjian, Cao, Ya
• Format: Article
• Language: English
• Subjects: Apoptosis - radiation effects; Carnitine O-Palmitoyltransferase - metabolism; Cell Line, Tumor; Fatty Acids - metabolism; Humans; Lipid Metabolism - radiation effects; Mitochondria - metabolism; Mitochondria - radiation effects; Nasopharyngeal Carcinoma - metabolism; Nasopharyngeal Carcinoma - radiotherapy; Nasopharyngeal Neoplasms - metabolism; Nasopharyngeal Neoplasms - radiotherapy; Oxidation-Reduction; Radiation Tolerance - radiation effects; Research Paper
• ISSN: 1838-7640; 1838-7640
• DOI: 10.7150/thno.21451

Nasopharyngeal carcinoma (NPC) has a particularly high prevalence in southern China, southeastern Asia and northern Africa. Radiation resistance remains a serious obstacle to successful treatment in NPC. This study aimed to explore the metabolic feature of radiation-resistant NPC cells and identify new molecular-targeted agents to improve the therapeutic effects of radiotherapy in NPC. : Radiation-responsive and radiation-resistant NPC cells were used as the model system and . Metabolomics approach was used to illustrate the global metabolic changes. C isotopomer tracing experiment and Seahorse XF analysis were undertaken to determine the activity of fatty acid oxidation (FAO). qRT-PCR was performed to evaluate the expression of essential FAO genes including . NPC tumor tissue microarray was used to investigate the prognostic role of CPT1A. Either RNA interference or pharmacological blockade by Etomoxir were used to inhibit CPT1A. Radiation resistance was evaluated by colony formation assay. Mitochondrial membrane potential, apoptosis and neutral lipid content were measured by flow cytometry analysis using JC-1, Annexin V and LipidTOX Red probe respectively. Molecular markers of mitochondrial apoptosis were detected by western blot. Xenografts were treated with Etomoxir, radiation, or a combination of Etomoxir and radiation. Mitochondrial apoptosis and lipid droplets content of tumor tissues were detected by cleaved caspase 9 and Oil Red O staining respectively. Liquid chromatography coupled with tandem mass spectrometry approach was used to identify CPT1A-binding proteins. The interaction of CPT1A and Rab14 were detected by immunoprecipitation, immunofluorescence and proximity ligation analysis. Fragment docking and direct coupling combined computational protein-protein interaction prediction method were used to predict the binding interface. Fatty acid trafficking was measured by pulse-chase assay using BODIPY C16 and MitoTracker Red probe. : FAO was active in radiation-resistant NPC cells, and the rate-limiting enzyme of FAO, carnitine palmitoyl transferase 1 A (CPT1A), was consistently up-regulated in these cells. The protein level of CPT1A was significantly associated with poor overall survival of NPC patients following radiotherapy. Inhibition of CPT1A re-sensitized NPC cells to radiation therapy by activating mitochondrial apoptosis both and . In addition, we identified Rab14 as a novel CPT1A binding protein. The CPT1A-Rab14 interaction facilitated